Praxis Medica
Sign in
Issue image

More articles from Volume 43, Issue 2, 2014

SISTEMATSKI PREGLED PRIMENE DIJAGRAMA TOKA U STUDIJAMA SA KLASTER RANDOMIZACIJOM

SLAGANJE DVA INSTRUMENTA ZA OCENU KVALITETA ŽIVOTA U DERMATOLOGIJI

RAZLIKE U KLINIČKIM KARAKTERISTIKAMA BOLESNIKA SA DILATACIONOM KARDIOMIOPATIJOM U ZAVSINOSTI OD POSTOJANJA OČUVANE KONTRAKTILNE REZERVE LEVE KOMORE PROCENJENE STRES EHOKARDIOGRAFSKIM TESTOM FIZIČKIM OPTEREĆENJEM

The use of antibiotics and their influence on course and outcome of bacterial meningitis in children before diagnosing it

ZNAČAJ PRICK TESTA U DIJAGNOSTICI ASTME KOD DECE

SISTEMATSKI PREGLED PRIMENE DIJAGRAMA TOKA U STUDIJAMA SA KLASTER RANDOMIZACIJOM

M. Kostic ,
M. Kostic
View authors publications

Search this author on:

PubMed | Google Scholar
A. Ilic ,
A. Ilic
View authors publications

Search this author on:

PubMed | Google Scholar
Z. Bukumiric ,
Z. Bukumiric
View authors publications

Search this author on:

PubMed | Google Scholar
J. Jovanovic ,
J. Jovanovic
View authors publications

Search this author on:

PubMed | Google Scholar
G. Trajkovic
G. Trajkovic
View authors publications

Search this author on:

PubMed | Google Scholar

Published: 01.12.2013.

Volume 43, Issue 2 (2014)

pp. 1-4;

https://doi.org/10.5937/pramed1402001k

Abstract

Dijagram toka studije predstavlja sastavni deo usklađenih standarda o izveštavanju (CONSORT). Preporučuje se njegova primena u izveštavanju ogleda sa klaster randomizacijom. Cilj rada je da se predstavi učestalost korišćenja dijagrama toka u klaster randomizovanim studijama u skladu sa standardima o izveštavanju. Urađeno je pretraživanje Medline-a i za analizu izdvojeno 474 studija sa klaster randomizacijom. Studije su pregledane u cilju otkrivanja upotrebe grafičkog prikaza, primene standarda o izveštavanju i vremena publikovanja studije. U zavisnosti od trajanja, studije su podeljene na one koje su prikazale završena istraživanja i one čije je izvođenje još uvek u toku. Učestalost dijagrama toka je bila statistički značajno veća u studijama koje su se pridržavale standarda (86,2%) u odnosu na studije koje nisu koristile CONSORT smernice (71,4%), i u studijama koje su prikazale završena istraživanja (81,2 %) u odnosu na studije koje su predstavljale pilot projekte (54,3%). Primena CONSORT-a je zabeležena u 145 (31%) literaturnih jedinica. Broj klaster randomizovanih studija dobijenih pretraživanjem MEDLINE-a niskom cluster randomized trial [ti] i cluster randomised trial [ti] i primena CONSORT-a u izveštajima klaster randomizovanih studija linearno rastu tokom vremena (p<0,001). Učestalost primene dijagrama toka je veća u izveštajima klaster randomizovanih studija koji su rađeni u skladu sa standardima o izveštavanju.

Keywords

graphic display,

CONSORT,

meta-analysis,

cluster randomized trials

References

1.
Eldridge S, Ashby D, Feder G, Rudnicka A, Ukoumunne O. Lessons for cluster randomized trials in the twenty-first century: a systematic review of trials in primary care. Clin Trials. 2004;(1).
2.
Kerry S, S. A Practical Guide to Cluster Randomised Trials in Health Services Research. 2012;
3.
Campbell M, Elbourne D, Altman D. CONSORT statement: extension to cluster randomised trials. BMJ. 2004;(7441):702–8.
4.
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA J Am Med Assoc. 1996;(8):637–9.
5.
Campbell M, Piaggio G, Elbourne D, Altman D. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;
6.
Lawrence H, Moulton R. 2009;
7.
Elbourne D, Campbell M. Extending the CONSORT statement to cluster randomized trials: for discussion. Stat Med. 2001;(3):489–96.
8.
Egger M, Juni P, Bartlett C. Value of flow diagrams in reports of randomized controlled trials. JAMA J Am Med Assoc. 2001;(15):1996–9.
9.
Toerien M, Brookes S, Metcalfe C, De Salis I, Tomlin Z, Peters T. A review of reporting of participant recruitment and retention in RCTs in six major journals. Trials. 2009;
10.
Hopewell S, Altman D, Moher D, Schulz K. Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal "Instructions to Authors. Trials. 2008;
11.
Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative beforeand-after evaluation. JAMA J Am Med Assoc. 2001;(15):1992–5.
12.
Plint A, Moher D, Morrison A, Schulz K, Altman D, Hill C. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust. 2006;(5):263–7.
13.
Ivers N, Taljaard M, Dixon S, Bennett C, Mcrae A, Taleban J. Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials. BMJ. 2000;(8).
14.
Bland J. Cluster randomised trials in the medical literature: two bibliometric surveys. BMC Med Res Methodol. 2004;
15.
Campbell M, Mollison J, Steen N, Grimshaw J, Eccles M. Analysis of cluster randomized trials in primary care: a practical approach. Fam Pract. 2000;(2):192–6.
16.
Brierley G, Brabyn S, Torgerson D, Watson J. Bias in recruitment to cluster randomized trials: a review of recent publications. J Eval Clin Pract. 2012;(4):878–86.
17.
Eldridge S, Ashby D, Bennett C, Wakelin M, Feder G. Internal and external validity of cluster randomised trials: systematic review of recent trials. BMJ. 2008;(7649):876–80.

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by
DOAJ
Google Scholar
ERIHPLUS
MIAR I
Crossref